EGFR and neoplasm: The aberrant fucosylation of tumor is always involved in the activation of EGFR or TGF-βR, and affect the function of integrins, selectins, and apoptotic signaling pathways; ultimately influencing tumor proliferation, invasion, apoptosis, and metastasis.